Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes

被引：0
|
作者：
Dengpiao Xie
Qiqi Wang
Wei Huang
Liangbin Zhao
机构：
[1] Hospital of Chengdu University of Traditional Chinese Medicine,
来源：
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词：
Dipeptidyl-peptidase-4 inhibitors; Inflammation; Type 2 diabetes mellitus; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1291 / 1301
页数：10
相关论文
共 50 条
  • [41] Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
    Lin, Yi-Hsin
    Huang, Hsuan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2725 - 2733
  • [42] Type 2 diabetes - Therapy with dipeptidyl peptidase IV inhibitors
    Demuth, HU
    McIntosh, CHS
    Pederson, RA
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1751 (01): : 33 - 44
  • [43] Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapy
    Yen, Fu-Shun
    Chiang, Jen-Huai
    Pan, Chun-Wei
    Lin, Boniface J.
    Wei, James Cheng-Chung
    Hsu, Chih-Cheng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 140 : 279 - 287
  • [44] Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Health in Patients with Type 2 Diabetes Mellitus
    Lee, Dong-Hwa
    Kim, Kyong Young
    Yoo, Min Young
    Moon, Hansol
    Ku, Eu Jeong
    Oh, Tae Keun
    Jeon, Hyun Jeong
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [45] Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
    Ametov, A. S.
    Gusenbekova, D. G.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (08) : 85 - 89
  • [46] Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes
    Bouchi, Ryotaro
    Fukuda, Tatsuya
    Takeuchi, Takato
    Nakano, Yujiro
    Murakami, Masanori
    Minami, Isao
    Izumiyama, Hajime
    Hashimoto, Koshi
    Yoshimoto, Takanobu
    Ogawa, Yoshihiro
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (02)
  • [47] Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Yagi, Shusuke
    Aihara, Ken-ichi
    Akaike, Masashi
    Fukuda, Daiju
    Salim, Hotimah Masdan
    Ishida, Masayoshi
    Matsuura, Tomomi
    Ise, Takayuki
    Yamaguchi, Koji
    Iwase, Takashi
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Matsumoto, Toshio
    Sata, Masataka
    DIABETES & METABOLISM JOURNAL, 2015, 39 (04) : 342 - 347
  • [48] Dipeptidyl peptidase-4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes
    Rouette, Julie
    Douros, Antonios
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB47 - AB47
  • [49] Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors
    Yang, Tzu-Lin
    Shen, Mei-Chiou
    Yu, Ming-Lung
    Huang, Yaw-Bin
    Chen, Chung-Yu
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2016, 24 (02) : 450 - 454
  • [50] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    不详
    JOURNAL OF DIABETES, 2009, 1 (01) : 6 - 7
12345